Early re-entry procedure. Part II. A five year histologic evaluation

Journal of Periodontology
B LangerD J Krutchkoff

Abstract

The following study was carried out to assess the histologic integrity of a bone graft which had appeared clinically successful at early re-entry some 5 years previously. The tooth required extraction due to a labial root fracture and was subsequently extracted in modified block section, demineralized, sectioned, stained and evaluated histologically. Histologic evaluation revealed the presence of a functional periodontal membrane apparatus in active stages of both bone and cemental remodeling. Necrotic bone spicules within the areas of otherwise viable periodontium suggested residue from prior graft material. Histologic evaluation presented here supports the previous clinical impression that early re-entry of autogenous grafts for evaluation and physiologic recontouring, where indicated, appears justified without apparent adverse effects on local periodontal regeneration.

References

Jun 1, 1977·Journal of Periodontology·B Langer, D A Gelb
Jun 1, 1979·Journal of Periodontology·B S MoskowS D Stein
May 1, 1975·Journal of Periodontology·C E Hawley, J Miller
Nov 1, 1975·Journal of Periodontology·S J FroumS S Stahl
May 1, 1968·Journal of Periodontology·R G Schallhorn
Apr 1, 1971·Journal of Periodontology·M M Rosenberg
Jun 1, 1971·Journal of Periodontology·M M Rosenberg
Aug 1, 1974·Journal of Periodontology·Benjamin Patur

❮ Previous
Next ❯

Citations

Dec 1, 1989·Journal of Periodontology·G M BowersE Romberg
Feb 1, 1996·Journal of Periodontology·M A Reynolds, G M Bowers
Aug 1, 1982·Journal of Periodontology·G M BowersJ T Mellonig
Jan 1, 1992·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·J T Mellonig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.